Infectious Diseases (all articles)
Podcast – Sinusitis: It’s Not That Tricky
29 Oct, 2020 | 08:55h | UTC#239 Sinusitis: It’s Not That Tricky – The Curbsiders Internal Medicine Podcast
WHO warns giving up on efforts to control Covid-19 would be ‘dangerous’
28 Oct, 2020 | 09:09h | UTCWHO warns giving up on efforts to control Covid-19 would be ‘dangerous’ – STAT
[Preprint] Cognitive deficits in people who have recovered from COVID-19 relative to controls: An N=84,285 online study
28 Oct, 2020 | 09:14h | UTCCommentaries: Recovered COVID-19 patients exhibit cognitive deficits – News Medical AND Expert reaction to preprint suggesting patients who recovered from COVID-19 could suffer serious cognitive decline – Science Media Centre
CDC Report on health care personnel hospitalized with COVID-19
28 Oct, 2020 | 09:17h | UTCCommentary: Nurses Make Up Most Hospitalized Coronavirus Health Care Workers, CDC Finds – U.S. News
Commentary on Twitter (thread – click for more)
BREAKING—huge CDC report on hospitalized healthcare workers w/ #COVID19, which comprise 1 in 16.7 (6%) of all hospitalized cases!
📌10% hospitalized had zero risk factor! (Median age only 49, so not old at all)
📌Whopping 36% hospitalized were nurses! 🧵https://t.co/IFRQSgWD8T pic.twitter.com/RtMeaX0lIN
— Eric Feigl-Ding (@DrEricDing) October 26, 2020
Lilly antibody drug fails in a Covid-19 study; others go on
28 Oct, 2020 | 09:10h | UTCLilly antibody drug fails in a Covid-19 study; others go on – CNBC
Outpatient management of COVID-19: Rapid evidence review
28 Oct, 2020 | 09:11h | UTCOutpatient Management of COVID-19: Rapid Evidence Review – American Family Physician
Perspective: Understanding COVID-19 vaccine efficacy
28 Oct, 2020 | 09:04h | UTCUnderstanding COVID-19 vaccine efficacy – Science
Commentary on Twitter
Having reliable evidence on direct & indirect protection #COVID19 candidate vaccines provide can help plan how to use approved vaccines in a coordinated way, write @mlipsitch & @nataliexdean in this #SciMagPerspective. https://t.co/AjAvrsGLb8 pic.twitter.com/CuKQ94NPE8
— Science Magazine (@ScienceMagazine) October 26, 2020
Study: Effectiveness of face masks in preventing airborne transmission of SARS-CoV-2
28 Oct, 2020 | 09:08h | UTCEffectiveness of Face Masks in Preventing Airborne Transmission of SARS-CoV-2 – mSphere
Commentary on Twitter
Study using actual #SARSCoV2, showing masks both prevent transmission and also protect uninfected people from inhaling the virus.
Both cotton and surgical masks blocked 50% of transmission, and even a cotton mask was able to reduce uptake by 20-40%.https://t.co/w3eLiVZ4CS pic.twitter.com/MlrgBL15Zl
— Dr Zoë Hyde (@DrZoeHyde) October 27, 2020
Latin America’s embrace of an unproven COVID treatment is hindering drug trials
28 Oct, 2020 | 09:01h | UTCLatin America’s embrace of an unproven COVID treatment is hindering drug trials – Nature
Chest CT in COVID-19: What the radiologist needs to know
28 Oct, 2020 | 08:59h | UTCChest CT in COVID-19: What the Radiologist Needs to Know – RadioGraphics
Preventing the spread of SARS-CoV-2 with masks and other “low-tech” interventions
27 Oct, 2020 | 09:51h | UTCPreventing the Spread of SARS-CoV-2 With Masks and Other “Low-tech” Interventions – JAMA
Commentary on Twitter
The essentiality of 😷😷 and low-tech tools even when vaccination programs are getting implemented. And call for universal masking now. https://t.co/Egyh0vjn5S by @NIAIDNews Andrea Lerner, Tony Fauci @JAMA_current pic.twitter.com/E1QeUW2bpE
— Eric Topol (@EricTopol) October 26, 2020
JACC Journal series gives in-depth look at COVID-19’s impact on the heart
27 Oct, 2020 | 09:49h | UTCNews release: Journal series gives in-depth look at COVID-19’s impact on the heart – American College of Cardiology
JACC Focus Seminar 1: Coronavirus and Cardiometabolic Syndrome
JACC Focus Seminar 2: Coronavirus Historical Perspective, Disease Mechanisms, and Clinical Outcomes
JACC Focus Seminar 3: Coronavirus and Cardiovascular Disease, Myocardial Injury, and Arrhythmia
SARS-CoV-2 antibodies detectable up to seven months post COVID-19 onset
27 Oct, 2020 | 09:44h | UTC
Commentary on Twitter
Neutralizing antibodies to SARS-CoV-2 Spike RBD, 40-199 days after symptom end:
– ~90% of patients have
– ~75% of them (~68%) have high titre (>300)
– no age difference
– higher in hospital cases and males
– lower with steroidsShould last a few years.https://t.co/OYZV6gRfyA https://t.co/Zdhj3W7yGw pic.twitter.com/eTUF870q05
— ice9 (@__ice9) October 24, 2020
COVID-19 – Lessons learned and questions remaining
27 Oct, 2020 | 09:46h | UTCCOVID-19 – Lessons Learned and Questions Remaining – Clinical Infectious Diseases
Commentary on Twitter
🔥Excellent article🔥
COVID-19 – Lessons Learned and Questions Remaining@CarlosdelRio7 @davidantibiotic https://t.co/c0VG4yyJXO pic.twitter.com/7Bxn1mVttT— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) October 26, 2020
CDC Guideline – Wastewater Surveillance System: A new public health tool to understand COVID-19 spread in a community
27 Oct, 2020 | 09:47h | UTCIntroduction: National Wastewater Surveillance System – Centers for Disease Control and Prevention
- Developing a Wastewater Surveillance Sampling Strategy
- Wastewater Surveillance Data Reporting & Analytics
- Public Health Interpretation and Use of Wastewater Surveillance Data
- Wastewater Surveillance Testing Methods
- Targeted Wastewater Surveillance at Facilities, Institutions, and Workplaces
Understanding protection from SARS-CoV-2 by studying reinfection
27 Oct, 2020 | 09:42h | UTCUnderstanding protection from SARS-CoV-2 by studying reinfection – Nature Medicine
COVID-19 antibody responses are related to the severity of symptoms
27 Oct, 2020 | 09:43h | UTCCommentaries: Studies show long-term COVID-19 immune response – CIDRAP AND COVID-19 immunity may be related to the severity of one’s symptoms, study finds – CTV News
Commentary on Twitter
A new paper @NatureMicrobiol shows the neutralizing antibody response to #SARSCoV2 is proportional to severity of illness, with longitudinal assessment, including a cohort of health care workers https://t.co/Ie4LAP8GZx @KingsCollegeLon and collaborators
— Eric Topol (@EricTopol) October 26, 2020
Perspective: It’s time to talk about Covid-19 and surfaces again
27 Oct, 2020 | 09:39h | UTCIt’s Time to Talk About Covid-19 and Surfaces Again – Wired
Commentary on Twitter
It’s Time to Talk About Covid-19 and Surfaces Again:
In the early days, we furiously scrubbed, afraid we could get sick from the virus lingering on objects and surfaces. What do we know now? https://t.co/vRdVVz6KMK via @GregoryJBarber— Ash Paul (@pash22) October 24, 2020
Covid-19: Six feet is not enough and 15 minutes is too long
27 Oct, 2020 | 09:38h | UTCSix Feet Is Not Enough and 15 Minutes Is Too Long – Medium
Review: Prospects for a safe COVID-19 vaccine
27 Oct, 2020 | 09:41h | UTCProspects for a safe COVID-19 vaccine – Science Translational Medicine
Universal mask use could save 130,000 U.S. lives by the end of February, new study estimates
25 Oct, 2020 | 23:51h | UTCUniversal mask use could save 130,000 U.S. lives by the end of February, new study estimates – STAT
Original Study: Modeling COVID-19 scenarios for the United States – Nature Medicine
Commentary on Twitter
Universal mask use could save up to 130k lives from September 22, 2020 through the end of February 2021 in the United States and avoid the need for more strict measures to contain the spread of #COVID19. Read now: https://t.co/TKhSusVnZl @IHME_UW @SimonHayHealer pic.twitter.com/XVS4PgInhT
— Nature Medicine (@NatureMedicine) October 23, 2020
Fauci says it might be time to mandate masks as Covid-19 surges across US
25 Oct, 2020 | 23:50h | UTCFauci says it might be time to mandate masks as Covid-19 surges across US – CNN
[Preprint] Randomized trial: Nitazoxanide does not improve symptoms in mild Covid-19 disease
25 Oct, 2020 | 23:46h | UTCEarly use of nitazoxanide in mild Covid-19 disease: randomized, placebo-controlled trial – medRxiv
Clinical Update: Virology, transmission, and pathogenesis of SARS-CoV-2
25 Oct, 2020 | 23:48h | UTCVirology, transmission, and pathogenesis of SARS-CoV-2 – The BMJ
Commentary on Twitter
https://twitter.com/bmj_latest/status/1320425173976256513
SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis
25 Oct, 2020 | 23:44h | UTC